4D pharma plc Recapitalization Costs
4D pharma plc reported Recapitalization Costs of $2.01 million for the 12-month period ending 2020-12-31, per its 6-K/A filed 2022-02-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RecapitalizationCosts · last filed 2022-02-18
| Period end | Recapitalization Costs 12 month |
|---|---|
| 2020-12-31 | $2.01M 6-K/A · filed 2022-02-18 |